Bioscience Plc Arix - Net Worth and Insider Trading

Bioscience Plc Arix Net Worth

The estimated net worth of Bioscience Plc Arix is at least $20 Million dollars as of 2024-11-13. Bioscience Plc Arix is the 10% Owner of Imara Inc and owns about 1,554,558 shares of Imara Inc (IMRA) stock worth over $10 Million. Bioscience Plc Arix is the 10% Owner of Harpoon Therapeutics Inc and owns about 219,370 shares of Harpoon Therapeutics Inc (HARP) stock worth over $5 Million. Bioscience Plc Arix is also the 10% Owner of LogicBio Therapeutics Inc and owns about 2,381,436 shares of LogicBio Therapeutics Inc (LOGC) stock worth over $5 Million. Besides these, Bioscience Plc Arix also holds Logic Devices Inc (LOGC) . Details can be seen in Bioscience Plc Arix's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bioscience Plc Arix has not made any transactions after 2020-09-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Bioscience Plc Arix

To

Bioscience Plc Arix Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bioscience Plc Arix owns 4 companies in total, including LogicBio Therapeutics Inc (LOGC) , Harpoon Therapeutics Inc (HARP) , and Imara Inc (IMRA) among others .

Click here to see the complete history of Bioscience Plc Arix’s form 4 insider trades.

Insider Ownership Summary of Bioscience Plc Arix

Ticker Comapny Transaction Date Type of Owner
LOGC LogicBio Therapeutics Inc 2020-09-28 10 percent owner
HARP Harpoon Therapeutics Inc 2020-05-28 10 percent owner
IMRA Imara Inc 2020-03-16 10 percent owner
LIMIT LIMIT 2020-03-11 10 percent owner

Bioscience Plc Arix Latest Holdings Summary

Bioscience Plc Arix currently owns a total of 4 stocks. Among these stocks, Bioscience Plc Arix owns 1,554,558 shares of Imara Inc (IMRA) as of March 16, 2020, with a value of $10 Million and a weighting of 49.62%. Bioscience Plc Arix owns 219,370 shares of Harpoon Therapeutics Inc (HARP) as of May 28, 2020, with a value of $5 Million and a weighting of 25.49%. Bioscience Plc Arix also owns 2,381,436 shares of LogicBio Therapeutics Inc (LOGC) as of September 28, 2020, with a value of $5 Million and a weighting of 24.89%. The other 1 stocks Logic Devices Inc (LOGC) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Bioscience Plc Arix

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMRA Imara Inc 2020-03-16 1,554,558 6.32 9,824,807
HARP Harpoon Therapeutics Inc 2020-05-28 219,370 23.01 5,047,704
LOGC LogicBio Therapeutics Inc 2020-09-28 2,381,436 2.07 4,929,573
LOGC Logic Devices Inc 2018-10-23 2,979,023 0.00 0

Holding Weightings of Bioscience Plc Arix


Bioscience Plc Arix Form 4 Trading Tracker

According to the SEC Form 4 filings, Bioscience Plc Arix has made a total of 1 transactions in Imara Inc (IMRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Imara Inc is the acquisition of 187,500 shares on March 16, 2020, which cost Bioscience Plc Arix around $3 Million.

According to the SEC Form 4 filings, Bioscience Plc Arix has made a total of 3 transactions in Harpoon Therapeutics Inc (HARP) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Harpoon Therapeutics Inc is the sale of 37,866 shares on May 28, 2020, which brought Bioscience Plc Arix around $8 Million.

According to the SEC Form 4 filings, Bioscience Plc Arix has made a total of 1 transactions in LogicBio Therapeutics Inc (LOGC) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in LogicBio Therapeutics Inc is the sale of 597,587 shares on September 28, 2020, which brought Bioscience Plc Arix around $5 Million.

More details on Bioscience Plc Arix's insider transactions can be found in the Insider Trading History of Bioscience Plc Arix table.

Insider Trading History of Bioscience Plc Arix

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bioscience Plc Arix Trading Performance

GuruFocus tracks the stock performance after each of Bioscience Plc Arix's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bioscience Plc Arix is 59.09%. GuruFocus also compares Bioscience Plc Arix's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bioscience Plc Arix within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bioscience Plc Arix's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bioscience Plc Arix

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.95 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -16.46 LIMIT LIMIT LIMIT LIMIT LIMIT

Bioscience Plc Arix Ownership Network

Ownership Network List of Bioscience Plc Arix

No Data

Ownership Network Relation of Bioscience Plc Arix

Insider Network Chart

Bioscience Plc Arix Owned Company Details

What does LogicBio Therapeutics Inc do?

Who are the key executives at LogicBio Therapeutics Inc?

Bioscience Plc Arix is the 10 percent owner of LogicBio Therapeutics Inc. Other key executives at LogicBio Therapeutics Inc include Chief Scientific Officer Mariana Nacht , Chief Medical Officer Daniel Gruskin , and Interim CFO Joshua Blacher .

LogicBio Therapeutics Inc (LOGC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of LogicBio Therapeutics Inc (LOGC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LogicBio Therapeutics Inc (LOGC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

LogicBio Therapeutics Inc (LOGC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

LogicBio Therapeutics Inc Insider Transactions

No Available Data

Bioscience Plc Arix Mailing Address

Above is the net worth, insider trading, and ownership report for Bioscience Plc Arix. You might contact Bioscience Plc Arix via mailing address: 20 Berkeley Square, London X0 W1j 6eq.